Volpara has acquired breast cancer risk assessment company CRA Health, LLC. Volpara Risk Pathways™ is a complete program for identifying and managing high-risk patients. Together we apply world-class knowledge about risk and genetics to prevent advanced-stage breast cancer.
Focus on breast cancer risk assessment
Breast cancer risk assessments performed annually
With major Electronic Health Records and genetic testing companies
Ask the Right Questions
Assess the risk of every patient
Patients can complete digital surveys at home or in the clinic to measure their lifetime and hereditary risk.
Align Risk Models & Guidelines
Find the right care plan
Access a set of up-to-date risk models and clinical guidelines to identify and stratify patients on their risk of developing breast cancer.
- Tyrer-Cuzick 6, 7, and 8
Genetics labs freedom of choice
Nimble interfaces with major genetics labs
Vendor-neutral test request forms reduce paper workflows, help with patient tracking, and allow you to use the lab or labs that best meets your needs.
Keep focus on the patient
Monitor your higher-risk population
A convenient, easy-to-use system tracks patient progress, updates risk profiles, generates communication, and triggers follow-up.
Empower providers and patients
The right message in the right method
Create educational or medical necessity communications for patients, physicians, and payers to advocate for and better coordinate care.
Technology for your workflow
EHR, cloud, or mammography reporting system
Proven IT integrations to streamline workflow. Seamless, integrated cancer risk assessment and decision support inside major EHRs, mammography reporting systems, or the cloud.